Amplification of c-myc in hepatocellular carcinoma: Correlation with clinicopathologic features, proliferative activity and p53 overexpression

Oncology

Volumn 57, Issue 2, 1999, Pages 157-163

  Kawate, Susumu ^a   Fukusato, Toshio ^b   Ohwada, Susumu ^a   Watanuki, Akira ^a   Morishita, Yasuo ^a  

^a GUNMA UNIVERSITY   (Japan)

^b GUNMA UNIVERSITY HOSPITAL   (Japan)

Author keywords

Argyrophilic nucleolar organizer regions; c myc amplification; MIB 1; p53; Polymerase chain reaction

Indexed keywords

ALPHA FETOPROTEIN; DOPAMINE 2 RECEPTOR; FORMALDEHYDE; KI 67 ANTIGEN; MONOCLONAL ANTIBODY KI 67; PROTEIN P53;

ADULT; AGED; ARGYROPHILIA; ARTICLE; CELL PROLIFERATION; CHROMOSOME NOR; CONTROLLED STUDY; FEMALE; GENE AMPLIFICATION; GENE EXPRESSION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LIVER CARCINOGENESIS; LIVER CELL CARCINOMA; LIVER REGENERATION; MAJOR CLINICAL STUDY; MALE; ONCOGENE C MYC; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; TUMOR SUPPRESSOR GENE; VIRUS HEPATITIS;

ADULT; AGED; CARCINOMA, HEPATOCELLULAR; CELL DIVISION; DNA PRIMERS; DNA, NEOPLASM; FEMALE; GENE AMPLIFICATION; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, MYC; HUMANS; LIVER NEOPLASMS; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION; PROGNOSIS; SURVIVAL ANALYSIS; TUMOR MARKERS, BIOLOGICAL; TUMOR SUPPRESSOR PROTEIN P53; UP-REGULATION;

EID: 0032820507     PISSN: 00302414     EISSN: None     Source Type: Journal    
DOI: 10.1159/000012024     Document Type: Article

References (36)

1. Perkins AS, Van de Woude GF: Principles of molecular cell biology of cancer: Oncogenes; in DeVita VT Jr, Hellman S, Rosenberg SA (eds): Cancer: Principles and Practice of Oncology, ed 4. Philadelphia, Lippincott, 1993, pp 35-59.
2. Thompson NL, Mead JE, Braum L, Goyette M, Shank PR, Fausto N: Sequential protooncogene expression during rat liver regeneration. Cancer Res 1986;46:3111-3117.
3. Makino R, Hayashi K, Sugimura T: c-myc transcript is induced in rat liver at a very early stage of regeneration or by cycloheximide treatment. Nature 1984;310:697-698.
4. Yaswen P, Goyette M, Shank PR, Fausto N: Expression of c-Ki-ras, c-Ha-ras and c-myc in specific cell types during hepatocarcinogenesis. Mol Cell Biol 1985;5:780-786.
5. Gan FY, Gesell MS, Alousi M, Luk GD: Analysis of ODC and c-myc gene expression in hepatocellular carcinoma by in situ hybridization and immunohistochemistry. J Histochem Cytochem 1993;41:1185-1196.
6. Arbuthnot P, Kew M, Fitschen W: c-fos and c-myc oncoprotein expression in human hepatocellular carcinomas. Anticancer Res 1991;11: 921-924.
7. Zhang XK, Huang DP, Qiu DK, Chiu JF: The expression of c-myc and c-N-ras in human cirrhotic livers, hepatocellular carcinomas and liver tissue surrounding the tumors. Oncogene 1990;5:909-914.
8. Saegusa M, Takano Y, Kishimoto H, Wakabayashi G, Nohga K, Okudaira M: Comparative analysis of p53 and c-myc expression and cell proliferation in human hepatocellular carcinoma: An enhanced immunohistochemical approach. J Cancer Res Clin Oncol 1993;119: 737-744.
9. Robinson WS: Molecular events in the pathogenesis of hepadnavirus-associated hepatocellular carcinoma. Annu Rev Med 1994;45:297-323.
10. Trowbridge R, Faga EA, Davison F, Eddleston ALWF, Williams R, Linskens MHK, Farzaneh E: Amplification of the c-myc gene locus in a human hepatic tumor containing integrated hepatitis B virus DNA; in Zuckerman AJ (ed): Viral Hepatitis and Liver Disease. New York, Liss, 1987, pp 764-768.
11. Peng SY, Lai PL, Hsu HC: Amplification of the c-myc gene in human hepatocellular carcinoma: Biologic significance. J Formos Med Assoc 1993;92:866-870.
12. Abou-Elella A, Gramlich T, Fritsch C, Gansler T: c-myc amplification in hepatocellular carcinoma predicts unfavorable prognosis. Mod Pathol 1996;9:95-98.
13. Frye RA, Benz CC, Liu E: Detection of amplified oncogenes by differential polymerase chain reaction. Oncogene 1989;4:1153-1157.
14. Neubauer A, Neubauer B, He M, Effert P, Iglehart D, Frye RA, Liu E: Analysis of gene amplification in archival tissue by differential polymerase chain reaction. Oncogene 1992;7: 1019-1025.
15. Underwood MA, Barlett JMS, Cooke TG: An improved method for semiquantification of gene amplification from archival material. PCR Methods Appl 1994;4:178-184.
16. Edmondson HA, Steiner PE: Primary carcinoma of the liver. A study of 100 cases among 48900 necropsies. Cancer 1954;7:462-503.
17. Gotoh M, Nakajima T, Yokota J, Tsunokawa Y, Terada M, Shimoyama Y, Teshima S, Hirohashi S, Shimosato Y: Newly established uterine cervical carcinoma cell line with co-amplification of human papillomavirus DNA and c-myc gene. Jpn J Cancer Res 1991;82:1252-1257.
18. Crocker J, Nar P: Nuclear organizer regions in lymphomas. J Pathol 1987;151:111-118.
19. Howat AJ, Giri DD, Wright AL, Underwood JCE: Silver-stained nucleoli and nucleolar organizer region counts are of no prognostic value in thick cutaneous malignant melanoma. J Pathol 1988;156:227-232.
20. Key G, Becker MHG, Baron B, Duchrow M, Schluter C, Flad HD, Gerdes J: New Ki-67-equivalent murine monoclonal antibodies (MIB 1-3) generated against bacterially expressed parts of the Ki-67 cDNA containing three 62 base pair repetitive elements encoding for the Ki-67 epitope. Lab Invest 1993;68:629-636.
21. Vojtesek B, Bartek J, Midgley CA, Lane DP. An immunochemical analysis of human nuclear phosphoprotein p53: New monoclonal antibodies and epitope mapping using recombinant p53. J Immunol Methods 1992;151: 237-244.
22. Liver Cancer Study Group of Japan: The general rules for the clinical and pathological study of primary liver cancer. Jpn J Surg 1989;19:98-129.
23. Kreipe H, Feist H, Fischer L, Felgner J, Heidorn K, Mettler L, Parwaresch R: Amplification of c-myc but not of c-erbB-2 is associated with high proliferative capacity in breast cancer. Cancer Res 1993;53:1956-1961.
24. Garte SJ: The c-myc oncogene in tumor progression. Crit Rev Oncog 1993;4:435-449.
25. Yokota J, Yokota YT, Battifora H, Fevre CL, Cline MJ: Alteration of myc, myb and rasHa proto-oncogenes in cancers are frequent and show clinical correlation. Science 1986;231: 261-265.
26. Transy C, Fourel G, Robinson WS, Tiollais P, Marion PL, Buendia MA: Frequent amplification of c-myc in ground squirrel liver tumors associated with past or ongoing infection with a hepadnavirus. Proc Natl Acad Sci USA 1992; 89:3874-3878.
27. Fujiwara Y, Monden M, Mori T, Nakamura Y, Emi M: Frequent multiplication of the long arm of chromosome 8 in hepatocellular carcinoma. Cancer Res 1993;53:857-860.
28. Baba M, Hasegawa H, Nakayabu M, Tamaki S, Watanabe S, Shima T, Suzuki S, Kusano I, Kamada N: Characteristics of human hepatocellular carcinoma cell lines (Hep-KANO) derived from a non-cirrhotic hepatitis B virus carrier. Jpn J Cancer Res 1994;85:1105-1111.
29. Jansen-Durr P, Meichle A, Steiner P, Pagano M, Finke K, Both J, Wessbecher J, Draetta G, Eilers M: Differential modulation of cyclin gene expression by MYC. Proc Natl Acad Sci USA 1993;90:3685-3689.
30. Goldblum JR, Bartos RE, Carr KA, Frank TS: Hepatitis B and alterations of the p53 tumor suppressor gene in hepatocellular carcinoma. Am J Surg Pathol 1993;17:1244-1251.
31. Gaidano G, Ballerini P, Gong JZ, Inghirami G, Neri A, Newcomb EW, Magrath IT, Knowles M, Dalla-Favera R: p53 mutation in human lymphoid malignancies: Association with Burkitt lymphoma and chronic lymphocytic leukemia. Proc Natl Acad Sci USA 1991;88:5413-5417.
32. Morkve O, Halvorsen OJ, Stangeland L, Gulsvik A, Laerum OD: Quantitation of biological tumor markers (p53, myc, Ki-67 and DNA ploidy) by multiparameter flow cytometry in non-small cell lung cancer. Int J Cancer 1992; 52:851-855.
33. Tabor E: Tumor suppressor genes, growth factor genes, and oncogenes in hepatitis B virus-associated hepatocellular carcinoma. J Med Virol 1994;42:357-365.
34. Brison O: Gene amplification and tumor progression. Biochim Biophys Acta 1993;1155: 25-41.
35. Shimizu K, Izumi R, Ii T, Muraoka K, Inoue T, Fukushima W, Sakamoto K, Tani T, Hashimoto T, Yagi M, Miyazaki I, Nonomura A: Prognostic significance of nucleolar organizer regions in hepatocellular carcinoma. Hepatology 1995;21:393-397.
36. Yoshimoto J, Iwata T, Takamori S, Kojima K, Hutagawa S: Usefulness of monoclonal antibody Ki-67 as a prognostic factor of hepatocellular carcinoma. Int Hepatol Commun 1997;6: 209-218.